Poly(C)-结合蛋白1在铁死亡中的研究进展

doi:10.16352/j.issn.1001-6325.2025.11.1501

基础医学与临床 ›› 2025, Vol. 45 ›› Issue (11): 1501-1505.doi: 10.16352/j.issn.1001-6325.2025.11.1501

Poly(C)-结合蛋白1在铁死亡中的研究进展

刘甜娜, 李阳, 邓雨笛, 吴富菊^*

吉林大学白求恩第二医院妇产科, 吉林长春 130041

收稿日期:2024-12-26 修回日期:2025-03-25 出版日期:2025-11-05 发布日期:2025-10-24
通讯作者: ^*wufj@jlu.edu.cn
基金资助:
吉林省科技发展计划(20230508077RC)

Progress on poly(C)-binding protein 1 in ferroptosis

LIU Tianna, LI Yang, DENG Yudi, WU Fuju^*

Department of Obstetrics and Gynecology,the Second Norman Bethune Hospital of Jilin University, Changchun 130041,China

Received:2024-12-26 Revised:2025-03-25 Online:2025-11-05 Published:2025-10-24
Contact: ^*wufj@jlu.edu.cn

摘要/Abstract

摘要： Poly(C)-结合蛋白1(PCBP1)是一种多功能RNA结合蛋白,参与基因转录,选择性修饰、翻译及铁代谢调节等过程。本文通过对PCBP1相关疾病如膀胱癌、头颈癌等的研究报道,探讨PCBP1抑制铁死亡的途径。PCBP1可以减少细胞内亚铁含量抑制铁死亡,包括抑制铁蛋白自噬,促进铁离子向铁蛋白或铁依赖性酶转移,稳定细胞内不稳定铁池及促进[2Fe-2S]簇生成;PCBP1还可以减少脂质过氧化物的生成,提高细胞对氧化应激的抵抗力来降低细胞内活性氧水平,从而抑制铁死亡。

关键词: poly(C)-结合蛋白1(PCBP1), 铁死亡, 铁蛋白, 脂质过氧化

Abstract: Poly(C)-binding protein 1 (PCBP1) is a multifunctional RNA-binding protein involved in a series of processes such as gene transcription, selective modification, translation and regulation of iron metabolism . This paper explores the pathway through which PCBP1 inhibits ferroptosis during the research on PCBP1-related diseases, such as bladder cancer and head and neck cancer. PCBP1 can reduce the intracellular ferrous iron content to inhibit ferroptosis through the mechanisms like inhibiting ferritinophagy,promoting the transfer of iron ions to ferritin or iron-dependent enzymes, stabilizing the labile iron pool within cells and facilitating the formation of[2Fe-2S] clusters. PCBP1 can also reduce the generation of lipid peroxides and enhance the resistance to oxidative stress thus to reduce the level of intracellular reactive oxygen thereby inhibiting ferroptosis.

Key words: poly(C)-binding protein 1 (PCBP1), ferroptosis, ferritin, lipid peroxidation

中图分类号:

刘甜娜, 李阳, 邓雨笛, 吴富菊. Poly(C)-结合蛋白1在铁死亡中的研究进展[J]. 基础医学与临床, 2025, 45(11): 1501-1505.

LIU Tianna, LI Yang, DENG Yudi, WU Fuju. Progress on poly(C)-binding protein 1 in ferroptosis[J]. Basic & Clinical Medicine, 2025, 45(11): 1501-1505.

参考文献 25

[1]	Huang S,Luo K,Jiang L,et al. PCBP1 regulates the transcription and alternative splicing of metastasis-related genes and pathways in hepatocellular carcinoma[J]. Scientific reports,2021,11: 23356.doi: 10.1038/s41598-021-02642-z.
[2]	Jiang XJ,Stockwell BR,Conrad M. Ferroptosis: mechanisms,biology and role in disease[J]. Nat Rev Mol Cell Biol,2021,22: 266-282.
[3]	Galy B,Conrad M,Mukenthaler M. Mechanisms control-ling cellular and systemic iron homeostasis[J]. Nat Rev Mol Cell Biol,2024,25: 133-155.
[4]	肖艳新,刘岩,许岭翎,等. 铁死亡在非酒精性脂肪性肝病发病中作用的研究进展[J]. 基础医学与临床,2024,44: 260-264.
[5]	Zheng Y,Zhou Z,Wei R,et al. The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin[J]. J Transl Med,2022,20: 1-18.
[6]	Lu Y,Liang Z,Guo H,et al. PCBP1 regulates alternative splicing of AARS2 in congenital cardiomyo-pathy[J]. bioRxiv,2023: 540420.doi: 10.1101/2023.05.18.5.0420.
[7]	Patel SJ,Protchenko O,Shakoury-Elizeh M,et al. The iron chaperone and nucleic acid-binding activities of poly(rC)-binding protein 1 are separable and independently essential[J]. Proc Natl Acad Sci U S A,2021,118: e2104666118.doi: 10.1073/pnas.2104666118.
[8]	Ryu MS,Zhang D,Protchenko O,et al. PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis[J]. J Clin Invest,2017,127: 1786-1797.
[9]	Ishii T,Igawa T,Hayakawa H,et al. PCBP1 and PCBP2 both bind heavily oxidized RNA but cause opposing outcomes,suppressing or increasing apoptosis under oxida-tive conditions[J]. J Biol Chem,2020,295: 12247-12261.
[10]	Xu Z,Li J,Zhou K,et al. Exocarpium citri grandis ameliorates LPS-induced acute lung injury by suppressing inflammation,NLRP3 inflammasome,and ferroptosis[J]. J Ethnopharmacol,2024,329:118162.doi:10.1016/j.jep.2024.118162.
[11]	Wang X,Fan A,Hong L. LncRNA MIR210HG promotes the proliferation of colon cancer cells by inhibiting ferroptosis through binding to PCBP1[J]. Sci Rep,2025,15:871. doi:10.1038/s41598-025-85321-7.
[12]	Hider R,Aviles M,Chen Y,et al. The role of GSH in intracellular iron trafficking[J]. Int J Mol Sci,2021,22:1278.doi:10.3390/ijms22031278.
[13]	Bayir H,Anthonymuthu TS,Tyurina YY,et al. Achieving life through death: redox biology of lipid peroxidation in ferroptosis[J]. Cell Chemical Biology,2020,27: 387-408.
[14]	Philpott C,Protchenko O,Wang Y,et al. Iron-tracking strategies: chaperones capture iron in the cytosolic labile iron pool[J]. Front Mol Biosci,2023,10:1127690.doi:10.3389/fmolb.2023.1127690.
[15]	Patel S,Protchenko O,Shakoury-Elizeh M,et al. The iron chaperone and nucleic acid-binding activities of poly(rC)-binding protein 1 are separable and independently essential[J]. Proc Natl Acad Sci U,2021,118:e2104666118.doi: 10.1073/pnas.2104666118.
[16]	Patel SJ,Frey AG,Palenchar DJ,et al. A PCBP1-BolA2 chaperone complex delivers iron for cytosolic[2Fe-2S] cluster assembly[J]. Nat Chem Biol,2019,15: 872-881.
[17]	Lee J,You J,Roh J. Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer[J]. Redox Biol,2022,51:102276.doi:10.1016/j.redox.2022.102276.
[18]	Luo Y,Zhang Y,Pang S,et al. PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation[J]. Mol Carcinog,2023,62: 907-919.
[19]	Jain C,Shah YM. PCBP1 is essential for proper iron absorption[J]. Blood,2023,142: 1585-1587.
[20]	Protchenko O,Baratz E,Jadhav S,et al. Iron chaperone poly rC binding protein 1 protects mouse liver from lipid peroxidation and steatosis[J]. Hepatology,2021,73: 1176-1193.
[21]	Kang Z,Fu Z,Tian X,et al. The role of PCBP1 in carbon ion-induced ferroptosis and inhibition of lung adenocarcinoma proliferation[J]. Front Public Health,2025,12:1496439. doi:10.3389/fpubh.2024.1496439.
[22]	Hacioglu C,Kar F,Davran F,et al. Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells[J]. Environ Toxicol,2023,38: 1690-1701.
[23]	Werth EG,Rajbhandari P,Stockwell BR,et al. Time course of changes in sorafenib-treated hepatocellular carcinoma cells suggests involvement of phospho-regulated signaling in ferroptosis induction[J]. Proteomics,2020,20:e2000006.doi:10.1002/pmic.202000006.
[24]	Ma H,Shi L,Li HT,et al. Polycytosine RNA-binding protein 1 regulates osteoblast function via a ferroptosis pathway in type 2 diabetic osteoporosis[J]. World J Diabetes,2024,15: 977-987.
[25]	Zhao Z,Luo P,Guo X,et al. Protein nanoparticles as potent delivery vehicles for polycytosine RNA-binding protein one[J]. World J Diabetes,2025,16:100675. doi:10.4239/wjd.v16.i1.100675.

Poly(C)-结合蛋白1在铁死亡中的研究进展

Progress on poly(C)-binding protein 1 in ferroptosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张玉锋, 张新娜, 周艳娇. PHLPP2变异和EGFR+TP53共突变与晚期肺腺癌预后及铁死亡相关[J]. 基础医学与临床, 2026, 46(1): 103-108.
[2]	李文华, 王润霖, 康乾鹏, 黄梅, 郭正光, 张春林, 黄永胜. p97抑制剂EerⅠ诱导胃癌细胞系AGS的凋亡与铁死亡[J]. 基础医学与临床, 2025, 45(11): 1401-1408.
[3]	付淼, 刘蓬, 田文, 王莎, 尹晓梅, 刘昊, 王东海. METTL3通过介导TRPM7甲基化调节宫颈癌细胞铁死亡和恶性进展[J]. 基础医学与临床, 2025, 45(10): 1318-1325.
[4]	肖艳红, 姜明东, 林叶远, 冉灿, 梁博. 灯盏花乙素抑制人前列腺癌细胞系PC-3的增殖和迁移[J]. 基础医学与临床, 2024, 44(9): 1229-1235.
[5]	叶俊武, 郑徐洲, 费林聪, 李漱阳, 杨天府. 重组人乳铁蛋白通过促进成骨细胞增殖加速大鼠骨折愈合[J]. 基础医学与临床, 2024, 44(7): 989-996.
[6]	王磊, 伍津津. 女性弥漫性脱发患者的微量营养素分析[J]. 基础医学与临床, 2024, 44(4): 513-517.
[7]	肖艳新, 刘岩, 许岭翎, 周亚茹. 铁死亡在非酒精性脂肪性肝病发病中作用的研究进展[J]. 基础医学与临床, 2024, 44(2): 260-264.
[8]	田宗源, 李展, 刘瑞霞. TERT调控线粒体氧化应激在疾病中的作用[J]. 基础医学与临床, 2024, 44(10): 1436-1441.
[9]	孙立杰, 郝丹丹. 诱导肝星状细胞铁死亡治疗肝纤维化的研究进展[J]. 基础医学与临床, 2024, 44(1): 108-113.
[10]	李想, 李晔. 非酒精性脂肪性肝病中自噬与铁死亡相互作用的研究进展[J]. 基础医学与临床, 2023, 43(8): 1294-1298.
[11]	郝丹丹, 张垒, 白春英. 靶向铁死亡治疗非酒精性脂肪性肝病的研究进展[J]. 基础医学与临床, 2023, 43(8): 1317-1321.
[12]	楚晓云, 蔡成. 铁死亡在新生儿急性肺损伤中作用机制的研究进展[J]. 基础医学与临床, 2023, 43(6): 1008-1011.
[13]	闫霖, 陆珏秀, 罗颖, 刘先霞. BM-MSCs来源外泌体介导铁死亡减轻大鼠心肌细胞系H9c2缺氧/复氧损伤[J]. 基础医学与临床, 2023, 43(5): 771-776.
[14]	向彩霞, 黄彬涛, 郝建. 抗凋亡抑制剂维奈克拉在治疗髓系白血病的研究进展[J]. 基础医学与临床, 2023, 43(5): 833-836.
[15]	曲大鹏, 孙会艳, 李强, 王洪权. 铁死亡在蛛网膜下腔出血早期脑损伤发病机制中作用的研究进展[J]. 基础医学与临床, 2023, 43(3): 486-489.